Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

ClinicalTrials.gov ID: NCT02137850

Public ClinicalTrials.gov record NCT02137850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 4:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Single-arm Multicentre Non-controlled Phase 3a Trial Investigating Safety and Efficacy of N8-GP in Prophylaxis and Treatment of Bleeding Episodes in Previously Untreated Paediatric Patients With Severe Haemophilia A

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted globally. The aim of the trial is to investigate the safety and efficacy of turoctocog alfa pegol (N8-GP) in previously untreated patients (PUPs) with haemophilia A.

Study identification

NCT ID
NCT02137850
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
124 participants

Conditions and interventions

Eligibility (public fields only)

Age range
0 Years to 6 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 26, 2014 (Actual)
Primary completion
Jun 7, 2023 (Actual)
Completion
Jun 7, 2023 (Actual)
Last update posted
Dec 23, 2025

2014 – 2023

United States locations

U.S. sites
34
U.S. states
21
U.S. cities
31
Facility City State ZIP Site status
Arizona H&T Phoenix Child Hosp Phoenix Arizona 85016-7710 —
Miller Children's Hospital Long Beach Long Beach California 90806 —
Children's Hospital Los Angeles - Endocrinology Los Angeles California 90027 —
Children's Hosp Of Orange Orange California 92868-3835 —
Harbor-UCLA Medical Center Torrance California 90502-2004 —
Shands Hospital at the University of Florida Gainesville Florida 32610 —
Nemours Chld Clnc Jacksonville Jacksonville Florida 32207 —
Nemours Child Orlando Hem/Onc Orlando Florida — —
St Joseph's Hospital Foundation Tampa Florida 33607 —
Emory University_Atlanta_1 Atlanta Georgia 30322 —
Medical College Of Georgia Augusta Georgia 30912 —
St. Luke's Mountain States Tumor Institute Boise Idaho 83712 —
Rush University Med. Cntr Chicago Illinois 60612 —
University Of Iowa Iowa City Iowa 52242 —
Tulane University School of Medicine New Orleans Louisiana 70112 —
Children's Hosp-New Orleans New Orleans Louisiana 70118-5720 —
Univ of NE Med Center_Omaha Omaha Nebraska 68198-6828 —
Hemostasis and Thrombosis Center of Nevada Las Vegas Nevada 89113 —
Rutgers-Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
The Brooklyn Hsptl Center Brooklyn New York 11201-5425 —
North Shore Long Island Jewish Medical Center New Hyde Park New York 11042 —
Torrence Hemby Ped Hem/Onc Ctr Charlotte North Carolina 28203 —
Novant Hlth Vasc Ins Charlotte Charlotte North Carolina 28204 —
Univ Hosp Cleveland Med Ctr Cleveland Ohio 44106 —
Dayton Children Hemostati Ctr Dayton Ohio 45404 —
Univ Oklahoma Sci Ctr OK City Oklahoma City Oklahoma 73104 —
Oregon Health & Science University_Portland_5 Portland Oregon 97239 —
Children's Hosptl Philadelphia Philadelphia Pennsylvania 19104 —
St Christopher Hosp for Child Philadelphia Pennsylvania 19134 —
Medical University Of SC Charleston South Carolina 29425 —
Vanderbilt Hemostasis Thrombosis Clinic Nashville Tennessee 37232 —
Univ of Utah Primary Children's Hospital Salt Lake City Utah 84113 —
University Of Virginia Hospitl Charlottesville Virginia 22908 —
Children's Hsptl Of The Kings Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02137850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 23, 2025 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02137850 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →